{"doi":"10.1002/mdc3.13906","title":"Early, Middle, and Late‐Stage Progression Rates in Progressive Supranuclear <scp>palsy‐Richardson</scp> Syndrome","abstract":"Supplemental Table 1 (Cohort 1, N=120): Demographics and progression rates. V1: visit when downgaze palsy was first detected. V2: last visit within 1 year of death. IQR: interquartile range; NS: statistically non-significant; Acceleration in green; Deceleration in yellow; SD: standard deviation. *: Statistically significant with more than 25% change, excluding ocular motor items, which correlate closely with downgaze palsy, our input measurement benchmark. Supplemental Table 2 (Cohort 2, N=42): Demographics and progression rates. V1: visit when downgaze palsy was first detected. Vm: visit when the maximal PSPRS item score of 4 was first detected. V2: last visit within 1 year of death. IQR: interquartile range; NS: statistically non-significant; Acceleration in green; Deceleration in yellow; SD: standard deviation. *: Statistically significant with more than 25% change, excluding ocular motor items, which correlate closely with downgaze palsy, our input measurement benchmark. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.","journal":"Movement Disorders Clinical Practice","year":2023,"id":368751,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9022,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1127126,"name":"Chuanhong Liao","orcid":"0000-0002-4186-0520","position":1,"is_corresponding":false},{"id":2899,"name":"Lawrence I. Golbe","orcid":"0000-0002-4373-3365","position":2,"is_corresponding":false},{"id":491843,"name":"Tao Xie","orcid":"0000-0001-9551-6613","position":0,"is_corresponding":true}],"reference_count":5,"raw_metadata":null,"created_at":"2026-07-19T01:15:24.517012Z","pmid":"38094650","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}